Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence
暂无分享,去创建一个
V. Nizet | N. Haste | S. A. Kristian | R. Gallo | M. Pence | Joshua Olson | Sascha A. Kristian | Hiruy S. Meharena
[1] V. Nizet,et al. β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus , 2013, Antimicrobial Agents and Chemotherapy.
[2] S. Mobashery,et al. Dissection of events in the resistance to β-lactam antibiotics mediated by the protein BlaR1 from Staphylococcus aureus. , 2012, Biochemistry.
[3] J.,et al. The New England Journal of Medicine , 2012 .
[4] S. Mobashery,et al. Activation of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus, Its Proteolytic Processing, and Recovery from Induction of Resistance* , 2011, The Journal of Biological Chemistry.
[5] V. Nizet,et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] L. Krippahl,et al. Evidence for a purifying selection acting on the β-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus , 2011, BMC Microbiology.
[7] S. Mobashery,et al. Binding of the gene repressor BlaI to the bla operon in methicillin-resistant Staphylococcus aureus. , 2010, Biochemistry.
[8] S. Cole,et al. Genome‐wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis , 2009, Molecular microbiology.
[9] V. Nizet,et al. M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition , 2009, Journal of Innate Immunity.
[10] K. Sayama,et al. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. , 2008, The Journal of antimicrobial chemotherapy.
[11] O. Schneewind,et al. Genome Sequence of Staphylococcus aureus Strain Newman and Comparative Analysis of Staphylococcal Genomes: Polymorphism and Evolution of Two Major Pathogenicity Islands , 2007, Journal of bacteriology.
[12] V. Nizet. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. , 2007, The Journal of allergy and clinical immunology.
[13] R. Proctor,et al. In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. , 2007, Microbiology.
[14] H. Sahl,et al. The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.
[15] V. Nizet,et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] V. Nizet. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. , 2006, Current issues in molecular biology.
[17] S. Mobashery,et al. β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome , 2005, Cellular and Molecular Life Sciences.
[18] V. Nizet,et al. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. , 2005, The Journal of clinical investigation.
[19] V. Nizet,et al. Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection , 2005, Molecular microbiology.
[20] G. Archer,et al. Crystal Structures of the BlaI Repressor from Staphylococcus aureus and Its Complex with DNA: Insights into Transcriptional Regulation of the bla and mec Operons , 2005, Journal of bacteriology.
[21] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[22] B. Barrell,et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Weidenmaier,et al. Bacterial resistance to antimicrobial host defenses--an emerging target for novel antiinfective strategies? , 2003, Current drug targets.
[24] Michael Otto,et al. Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.
[25] R. Lewis,et al. MecI represses synthesis from the β-lactamase operon of Staphylococcus aureus , 2000 .
[26] R. Lewis,et al. MecI represses synthesis from the beta-lactamase operon of Staphylococcus aureus. , 2000, The Journal of antimicrobial chemotherapy.
[27] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[28] H. Kalbacher,et al. Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.
[29] A. Conde. Staphylococcus aureus infections. , 1998, The New England journal of medicine.
[30] C. Rubens,et al. Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. , 1998, Gene.
[31] E. Maguin,et al. New thermosensitive plasmid for gram-positive bacteria , 1992, Journal of bacteriology.
[32] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[33] N. Fairweather,et al. Expression of a cloned Staphylococcus aureus alpha-hemolysin determinant in Bacillus subtilis and Staphylococcus aureus , 1983, Infection and immunity.
[34] Eugene Rosenberg,et al. Adherence of bacteria to hydrocarbons: A simple method for measuring cell‐surface hydrophobicity , 1980 .
[35] C. O'callaghan,et al. Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate , 1972, Antimicrobial Agents and Chemotherapy.